Epoch Biodesign Raises $12 Million in Strategic Funding Round
Epoch Biodesign, a company based in London, England, has successfully closed a $12 million strategic funding round. The company specializes in producing virgin-quality recycled polymer with minimal emissions, focusing initially on nylon 6,6. This funding marks a significant step in their mission to enhance sustainable materials through advanced recycling technologies.
Investors and Industry Support
This funding round saw participation from a diverse group of investors, including lululemon, KOMPAS VC, Happiness Capital, Extantia, and Leitmotif. The involvement of such prominent names underscores the growing interest in sustainable materials and recycling technologies.
Company Leadership
Epoch Biodesign was founded by Jacob Nathan, who also serves as the CEO. Nathan's leadership has been pivotal in steering the company towards innovative solutions in enzymatic recycling processes.
Scaling Production
The funds raised will be directed towards scaling the production of recycled nylon from a pilot facility to a larger demonstration site. This expansion is aimed at validating the commercial-scale output of their recycling technology. By doing so, Epoch Biodesign aims to meet the rising demand for sustainable materials in various industries.
The Path Ahead
With this new capital, Epoch Biodesign is well-positioned to advance its capabilities in the recycling sector, potentially setting new standards for sustainability in polymer production. As the company scales its operations, it will likely continue to draw attention from both investors and companies seeking eco-friendly material solutions.